KIF2C Accelerates the Development of Non-Small Cell Lung Cancer and Is Suppressed by miR-186-3p via the AKT-GSK3β-β-Catenin Pathway

Scientists clarified the ability of kinesin family member 2C (KIF2C) to enhance cancer cell viability, proliferation, and invasion in NSCLC by activating the AKT-GSK3β-β-catenin pathway.